PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Rheumatology and Immunology, University Hospital, Bern, Switzerland.\', \'Department of BioMedical Research, University of Bern, Bern, Switzerland.\', \'Saiba AG, Pfaeffikon, Switzerland.\', \'Latvian Biomedical Research & Study Centre, Riga, Latvia.\', \'International Immunology Center, Anhui Agricultural University, Hefei, China.\', \'Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), The Jenner Institute, University of Oxford, Oxford, UK.\', \'Musculoskeletal Research Unit (MSRU), Department of Molecular Mechanisms of Disease (DMMD), Vetsuisse Faculty, University of Zurich (UZH), Zurich, Switzerland.\', \'Erasmus Medical Center, department of Viroscience, Rotterdam, The Netherlands.\', \'Artemis Bio-Support, Delft, The Netherlands.\', \'Department of Dermatology, University Hospital Zurich (USZ), University of Zurich (UZH), Zurich, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/all.15080
?:hasPublicationType
?:journal
  • Allergy
is ?:pmid of
?:pmid
?:pmid
  • 34496033
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34496033>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34496033>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all